Non-alcoholic fatty liver disease and cardiovascular risk

被引:76
|
作者
Brea, Angel [1 ]
Puzo, Jose [2 ]
机构
[1] Hosp San Pedro, Unidad Lipidos, Serv Med Interna, Logrono, Spain
[2] Hosp San Jorge, Unidad Lipidos, Bioquim Clin, Huesca, Spain
关键词
Fatty liver; Cardiovascular disease; Alcohol; Non-alcoholic fatty liver disease; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-HEART-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; ENDOPLASMIC-RETICULUM STRESS; RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; HEPATIC STEATOSIS; METABOLIC SYNDROME; INSULIN-RESISTANCE; WEIGHT-LOSS;
D O I
10.1016/j.ijcard.2012.09.085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term "Non-alcoholic fatty liver disease" (NAFLD) covers a series of liver lesions similar to those induced by alcohol, but not caused by alcohol use. The importance of NAFLD lies in the high prevalence in Western societies and, from the point of view of the liver, in its progression from steatosis to cirrhosis and liver cancer. More recently, NAFLD has been found to be associated with lipid metabolism disorders, the deposition of fat outside of the adipocytes, insulin resistance and Metabolic Syndrome. Also attributed to NAFLD is a heightened systemic pro-inflammatory state, which accelerates arteriosclerosis, thereby increasing cardiovascular risk and associated cardiovascular events. Here we provide an update to the etiopathogenesis of NAFLD, its influence on cardiovascular disease, and the treatment options. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1109 / 1117
页数:9
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
    Bhatia, Lokpal S.
    Curzen, Nicholas P.
    Calder, Philip C.
    Byrne, Christopher D.
    EUROPEAN HEART JOURNAL, 2012, 33 (10) : 1190 - +
  • [2] Non-alcoholic fatty liver disease and risk of cardiovascular disease
    Lonardo, Amedeo
    Sookoian, Silvia
    Pirola, Carlos J.
    Targher, Giovanni
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1136 - 1150
  • [3] Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
    Ballestri, Stefano
    Lonardo, Amedeo
    Bonapace, Stefano
    Byrne, Christopher D.
    Loria, Paola
    Targher, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (07) : 1724 - 1745
  • [4] Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk
    Ahmed, Mohamed H.
    Husain, Nazik Elmalaika
    Malik, Akif
    Woodward, Clare
    Mital, Dushyant
    AIDS REVIEWS, 2017, 19 (04) : 190 - 197
  • [5] Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
    Tana, Claudio
    Ballestri, Stefano
    Ricci, Fabrizio
    Di Vincenzo, Angelo
    Ticinesi, Andrea
    Gallina, Sabina
    Giamberardino, Maria Adele
    Cipollone, Francesco
    Sutton, Richard
    Vettor, Roberto
    Fedorowski, Artur
    Meschi, Tiziana
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (17)
  • [6] Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk
    Targher G.
    Current Cardiovascular Risk Reports, 2010, 4 (1) : 32 - 39
  • [7] Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
    Targher, Giovanni
    Arcaro, Guido
    ATHEROSCLEROSIS, 2007, 191 (02) : 235 - 240
  • [8] Current therapeutic strategies in non-alcoholic fatty liver disease
    Dowman, J. K.
    Armstrong, M. J.
    Tomlinson, J. W.
    Newsome, P. N.
    DIABETES OBESITY & METABOLISM, 2011, 13 (08): : 692 - 702
  • [9] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [10] Non-alcoholic fatty liver disease and cardiovascular risk
    Brea Hernando, Angel
    Puzo Foncillas, Jose
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (06): : 259 - 271